by dm@cosydian.com | Jun 30, 2022 | Uncategorised
Researchers at the University of Manchester have made a discovery which could potentially lead to a new treatment for Alzheimer’s disease. The team have discovered changes to the blood vessels in the brain in those with the condition, which may lead to the development...
by dm@cosydian.com | Jun 24, 2022 | Uncategorised
The NHS is set to roll out two new antimicrobial drugs, after they were acquired through a new subscription scheme. Under the agreement, NHS England pays a fixed annual fee to pharmaceutical firms, in return for the supply of new antimicrobial drugs. The first deal...
by dm@cosydian.com | Jun 22, 2022 | Uncategorised
There has been a warning that a shortage of the drug diamorphine, which is used as a clinical substitute for heroin, may be causing severe problems for patients in England. The BBC reports that diamorphine is prescribed to heroin addicts who don’t respond to...
by dm@cosydian.com | Jun 20, 2022 | Uncategorised
A UK start-up has developed a pioneering cancer test that has already gained US regulatory clearance. Angle, who are based in Surrey and listed in London, have attracted the interest of global pharmaceutical companies after their liquid biopsy test was given clearance...
by dm@cosydian.com | Jun 14, 2022 | Uncategorised
A new injectable eye medicine has been recommended as a treatment option by the National Institute for Health and Care Excellence (NICE) for two forms of sight loss. The Pharma Times reports that Faricimab has been developed by Roche to treat wet age-related macular...
by dm@cosydian.com | Jun 6, 2022 | Uncategorised
A new asthma therapy which is being developed by AstraZeneca in collaboration with Avillion has shown positive results from a phase 3 trial. The Pharma Times reports that the treatment, known as PT027, is a fixed-dose combination of albuterol and budesonide. The novel...
Recent Comments